Ichor (NASDAQ:ICHR – Get Free Report) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided EPS guidance of $0.21-0.33 for the period, compared to the consensus EPS estimate of $0.21. The company issued revenue guidance of $220-235 million, compared to the consensus revenue estimate of $216.19 million.
Ichor Stock Performance
Shares of NASDAQ:ICHR traded down $0.21 during midday trading on Monday, reaching $27.14. 239,127 shares of the company traded hands, compared to its average volume of 305,293. Ichor has a 12 month low of $22.26 and a 12 month high of $46.43. The firm’s fifty day moving average price is $28.95 and its two-hundred day moving average price is $33.87. The company has a quick ratio of 1.91, a current ratio of 4.27 and a debt-to-equity ratio of 0.18. The firm has a market capitalization of $914.35 million, a price-to-earnings ratio of -22.62 and a beta of 1.91.
Ichor (NASDAQ:ICHR – Get Free Report) last posted its earnings results on Tuesday, August 6th. The technology company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02. The business had revenue of $203.23 million for the quarter, compared to analyst estimates of $197.75 million. Ichor had a negative net margin of 4.53% and a negative return on equity of 2.56%. On average, equities analysts expect that Ichor will post -0.17 earnings per share for the current year.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on ICHR
Ichor Company Profile
Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment in the United States and internationally. It primarily offers gas and chemical delivery systems and subsystems that are used in the manufacturing of semiconductor devices.
Featured Articles
- Five stocks we like better than Ichor
- How Can Investors Benefit From After-Hours Trading
- Intel: Is Now the Time to Be Brave?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Election Stocks: How Elections Affect the Stock Market
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Ichor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ichor and related companies with MarketBeat.com's FREE daily email newsletter.